skip to main content

H.R. 153 (117th): Protecting Consumer Access to Generic Drugs Act of 2021

To prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Bobby Rush

Sponsor. Representative for Illinois's 1st congressional district. Democrat.

Read Text »
Last Updated: Jan 4, 2021
Length: 20 pages
Introduced
Jan 4, 2021
117th Congress (2021–2023)
Status
Died in a previous Congress

This bill was introduced on January 4, 2021, in a previous session of Congress, but it did not receive a vote.

Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).

Cosponsors

18 Cosponsors (17 Democrats, 1 Republican)

Source

History

Jan 4, 2021
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

May 4, 2021
 
Considered by Health

A committee held a hearing or business meeting about the bill.

H.R. 153 (117th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 153. This is the one from the 117th Congress.

This bill was introduced in the 117th Congress, which met from Jan 3, 2021 to Jan 3, 2023. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 153 — 117th Congress: Protecting Consumer Access to Generic Drugs Act of 2021.” www.GovTrack.us. 2021. October 3, 2023 <https://www.govtrack.us/congress/bills/117/hr153>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.